B4GALT6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.106000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.070800E-01
Normal-vs-Stage2
9.537400E-01
Normal-vs-Stage3
7.276300E-02
Normal-vs-Stage4
5.372800E-01
Stage1-vs-Stage2
1.110840E-01
Stage1-vs-Stage3
1.242350E-01
Stage1-vs-Stage4
2.942400E-01
Stage2-vs-Stage3
8.422400E-03
Stage2-vs-Stage4
6.411200E-01
Stage3-vs-Stage4
4.586600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.288800E-01
Normal-vs-AfricanAmerican
1.744780E-01
Normal-vs-Asian
3.164000E-01
Caucasian-vs-AfricanAmerican
1.819790E-02
Caucasian-vs-Asian
1.593000E-01
AfricanAmerican-vs-Asian
3.564400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.831200E-01
Normal-vs-Female
7.922000E-01
Male-vs-Female
2.329400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.140000E-01
Normal-vs-Age(41-60Yrs)
7.946000E-01
Normal-vs-Age(61-80Yrs)
9.379600E-01
Normal-vs-Age(81-100Yrs)
7.318800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.363400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.170800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.008400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.639600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.542000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.898600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.746200E-01
Normal-vs-Daily Drinker
9.152400E-01
Normal-vs-Weekly Drinker
1.709350E-01
Normal-vs-Occasional Drinker
7.113800E-01
Normal-vs-Social Drinker
6.192400E-01
Non Drinker-vs-Daily Drinker
4.222600E-01
Non Drinker-vs-Weekly Drinker
3.078000E-01
Non Drinker-vs-Occasional Drinker
1.752360E-01
Non Drinker-vs-Social Drinker
1.316820E-01
Daily Drinker-vs-Weekly Drinker
1.783030E-01
Daily Drinker-vs-Occasional Drinker
6.458600E-01
Daily Drinker-vs-Social Drinker
5.136800E-01
Weekly Drinker-vs-Occasional Drinker
6.217900E-02
Weekly Drinker-vs-Social Drinker
5.054400E-02
Occasional Drinker-vs-Social Drinker
8.255800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.211590E-01
Normal-vs-Grade 2
1.263430E-01
Normal-vs-Grade 3
7.970000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.151730E-02
Grade 1-vs-Grade 3
1.133950E-02
Grade 1-vs-Grade 4
1.211590E-01
Grade 2-vs-Grade 3
9.245800E-01
Grade 2-vs-Grade 4
1.263430E-01
Grade 3-vs-Grade 4
7.970000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.167000E-01
Normal-vs-NonDiabetic
9.055400E-01
Diabetic-vs-NonDiabetic
1.389960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.230000E-01
Normal-vs-NoPancreatitis
9.993800E-01
Pancreatitis-vs-NoPancreatitis
4.325000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.803400E-01
Normal-vs-N1
9.236800E-01
N0-vs-N1
7.633700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.304800E-01
Normal-vs-TP53-NonMutant
6.976000E-02
TP53-Mutant-vs-TP53-NonMutant
1.56498999999144E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
